Potential therapeutic uses of mecamylamine and its stereoisomers. - Wikidata - wikimedia - TriplyDB

Potential therapeutic uses of mecamylamine and its stereoisomers.

Potential therapeutic uses of mecamylamine and its stereoisomers.

http://www.wikidata.org/entity/Q36949979

about

Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation Differential Gene Expression Profile in the Rat Caudal Vestibular Nucleus is Associated with Individual Differences in Motion Sickness Susceptibility Intra-nucleus accumbens shell injections of R(+)- and S(-)-baclofen bidirectionally alter binge-like ethanol, but not saccharin, intake in C57Bl/6J mice.Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors.Neuronal Nicotinic Acetylcholine Receptor Modulators Reduce Sugar Intake.Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.Anxiolytic- and antidepressant-like effects of the methadone metabolite 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP).Phase II drugs that target cholinergic receptors for the treatment of overactive bladder.Pharmaceuticals that contain polycyclic hydrocarbon scaffolds.Blockade of cholinergic transmission elicits somatic signs in nicotine-naïve adolescent rats.Possible involvement of transient receptor potential ankyrin 1 in Ca2+ signaling via T-type Ca2+ channel in mouse sensory neurons.Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy.

P2860

Q26774830-13DF5EB9-223B-49F9-ACA7-A891314DEA11 Q27309183-C5519B40-FB75-4323-8A55-246A2C5F1058 Q34052435-C1639652-7C05-4BB5-BD64-F7F6E362B554 Q34394190-56924B2D-DBE7-4251-A469-EB8750096038 Q35974049-56BAFAA9-2FDA-4174-8267-CBFEC87F5306 Q36372867-5C9447AD-832E-4AE0-A5CD-C0F1E1F4B4B7 Q36378201-A813B671-9C30-4815-8617-04F74C1AD982 Q38217760-BFE68985-915F-43C0-90DF-F3A392E08CB7 Q38546598-58B28103-59E3-4F58-8BEC-0810423C82F6 Q43212820-BC70257E-FCF7-4900-9A88-354DF89F4CEE Q47240731-5805759C-4C51-455D-8778-38C6851315B9 Q48131663-0867A53D-52D8-4718-A86F-0FB4F9BB6F17

P2860

Potential therapeutic uses of mecamylamine and its stereoisomers.

http://www.wikidata.org/entity/Q36949979

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Potential therapeutic uses of mecamylamine and its stereoisomers.

@en

type

label

Potential therapeutic uses of mecamylamine and its stereoisomers.

@en

prefLabel

Potential therapeutic uses of mecamylamine and its stereoisomers.

@en

P1433

Q36949979-FDDE6F28-6B9F-45D5-8DBB-83793ECFD4C2

P1476

Q36949979-98FC93F1-7C94-40D2-80EC-ACE5BEFD5921

P2093

Q36949979-43FF6D94-062A-42E1-B13F-BFBFAB5009FD

Q36949979-57B52FF9-B6A4-4B9A-AF54-652CEB656ADD

Q36949979-782BD538-4345-4133-9DD6-F8916CE22C5D

Q36949979-AF8AD008-E151-4D45-88C9-F9F418C67F93

Q36949979-C00CDB1E-CB16-43A1-AAEC-09DDBADEA9C6

P2860

Q36949979-00C18466-D8C8-400D-B030-FC130E1B165C

Q36949979-015641EA-0AF2-494E-B16F-626769F6F19A

Q36949979-04C81A38-E9B2-4DB0-9621-E07843343BC3

Q36949979-05CB07CE-52B9-4FFA-A4FF-8E7AA9572ACB

Q36949979-06548460-9482-4478-8EAB-C00410AE74DB

Q36949979-06A2DF77-CA85-42C2-BF85-8E0968E21D32

Q36949979-0713911C-7342-4312-A260-54EED232B9FC

Q36949979-077E6ABE-EE29-4D3E-A545-ECAA4BBCB6E0

Q36949979-094E62A8-E7B8-433C-9080-E77D1084A085

Q36949979-0BCB05AA-4579-44BA-A724-BDF4FD73E2DA

P304

Q36949979-8FF9DE7B-2E90-400C-AEA5-83DB3E8AAF93

P31

Q36949979-85711FB7-C65E-4439-B881-2B30937C07D7

P356

Q36949979-0AC7541F-BEF0-4FCB-AC7E-6B2342B998DA

P407

Q36949979-CD9520FA-7F24-493A-BF08-E44A3CAB116D

P478

Q36949979-73248A73-955E-4B63-A635-6AA9BBC8F9A5

P577

Q36949979-8A5B44F7-73CD-4B4D-B186-9E003787F2C7

P698

Q36949979-EAF77C27-6DC5-404E-882A-5F30647D3C78

P932

Q36949979-6E07E6BC-82F6-4C37-9582-A5DF03E262EC

P356

J.PBB.2013.04.005

P1433

Pharmacology, Biochemistry and Behavior

P1476

Potential therapeutic uses of mecamylamine and its stereoisomers.

@en

P2093

Andrew M Smith

http://www.w3.org/2001/XMLSchema#string

Justin R Nickell

http://www.w3.org/2001/XMLSchema#string

Kiran B Siripurapu

http://www.w3.org/2001/XMLSchema#string

Linda P Dwoskin

http://www.w3.org/2001/XMLSchema#string

Vladimir P Grinevich

http://www.w3.org/2001/XMLSchema#string

P2860

Studies on the mechanism of action of acetylcholine antagonists on rat parasympathetic ganglion cells

Desensitization of nicotinic acetylcholine receptors as a strategy for drug development.

Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Preclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype

A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder

Mecamylamine (Inversine): an old antihypertensive with new research directions

Nicotinic acetylcholine receptors: from structure to brain function

Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes

Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers.

P304

28-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PBB.2013.04.005

http://www.w3.org/2001/XMLSchema#string

P407

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23603417

http://www.w3.org/2001/XMLSchema#string

P932

3690754

http://www.w3.org/2001/XMLSchema#string